Keratoprosthesis: procedure of choice for corneal opacities in children?

Sudha Nallasamy1, Kathryn Colby

  • 1Department of Ophthalmology, Children's Hospital Boston, MA, USA.

Seminars in Ophthalmology
|November 25, 2010
PubMed

Insights

Boston keratoprosthesis offers a viable alternative to pediatric keratoplasty, providing clear vision and stable outcomes. Long-term care is essential for success in children with amblyogenic potential.

Area of Science:

  • Ophthalmology
  • Pediatric Ophthalmology
  • Corneal Surgery

Background:

  • Pediatric corneal transplantation (keratoplasty) faces significant challenges, including graft clarity issues, suboptimal visual acuity, and high rejection rates.
  • Keratoprosthesis offers a potential solution for complex pediatric corneal diseases.

Observation:

  • The Boston type I keratoprosthesis demonstrates rapid achievement of a clear visual axis and stable refractive error.
  • Unlike allografts, keratoprosthesis eliminates the risk of immune rejection.

Findings:

  • Penetrating keratoplasty in children has poor graft survival (44% at 50 months) and visual outcomes (30-34% achieving 20/400).
  • High rates of allograft rejection (40-50%) complicate pediatric keratoplasty.
  • Boston keratoprosthesis requires lifelong management, including topical medications, bandage contact lenses, and interventions for complications like retroprosthetic membranes and glaucoma.

Implications:

  • The Boston keratoprosthesis can lead to successful anatomical and functional outcomes in pediatric patients of amblyogenic age, provided parental commitment.
  • Careful patient selection and long-term follow-up are crucial for optimizing results with pediatric keratoprosthesis.
Abstract

Related Concept Videos